PMOS reveals the long road to truly personalized health
TL;DR
Victoria Song argues that renaming PCOS to PMOS reflects a broader hormonal and metabolic condition, and that personalized health tech is not yet capable of reliably addressing chronic illnesses. While wearables and AI promise tailored guidance, PMOS manifests differently across individuals, interacts with insulin resistance and medications, and is influenced by factors like hormonal contraception, making universal personalization elusive. Despite industry optimism, real-world personalization still requires significant self-tracking, medical input, and trial-and-error, highlighting a gap between hype and what current science and healthcare systems can safely deliver.
- The promises and pitfalls of personalized health The Verge
- Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide Endocrine Society
- P.C.O.S. Has a New Name. Doctors Hope It Will Improve Care for Millions. The New York Times
- ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women The Guardian
- The Condition Known as PCOS Has a New Name Time Magazine
Want the full story? Read the original reporting
Read on The Verge